The GUARDIAN Trial
Tight Perioperative Blood Pressure Management to Reduce Serious Cardiovascular, Renal, and Cognitive Complications: The GUARDIAN Trial
Sponsor: The University of Texas Health Science Center, Houston
A NA clinical study on Blood Pressure, this trial is actively recruiting participants. The trial is conducted by The University of Texas Health Science Center, Houston and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2022 — Sep 2023 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Texas Health Science Center, Houston
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bakırköy, Turkey (Türkiye) , Beijing, China , Chengdu, China , Cleveland, United States , Hong Kong, China , Houston, United States , Konya, Turkey (Türkiye) , Larissa, Greece , Omaha, United States , Rome, Italy and 4 more locations